In addition, syndecan-1, a transmembrane heparan sulfate proteoglycan, has been specified as a potential marker for tumor progression, with reduced expression correlating with increased invasiveness as reported for a case series for CSCC (9, 39). The gene discussed is SDC1; the disease is neoplasm.